CMPX.O (CMPX.O) News
Follow CMPX.O (CMPX.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BRIEF — Compass Announces Inducement Grants Under Nasdaq Listing Rule
Oct 14 (Reuters) — Compass Therapeutics Inc.: Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Source text:... Further company coverage: CMPX.O (reuters.briefs@thomsonreuters.com;)
NEWS | Oct 14, 2026, 09:47 PM UTC
L
Compass Therapeutics Grants New Employee Stock Options for 200,000 Shares
Compass Therapeutics granted a new employee non-qualified stock options to purchase 200,000 common shares under its 2025 Inducement Plan. The options have a $0.86 per-share exercise price and a 10-year term. Vesting span
EQUITY | Oct 14, 2026, 08:33 PM UTC